Venus Remedies jumped 8.09% to Rs 298 at 12:04 IST on BSE after the company said that its wholly owned subsidiary entered into a distribution-cum-outlicensing agreement with Mylan for marketing its generic meropenem, in 3 European countries.
The announcement was made during market hours today, 8 September 2014.
Meanwhile, the S&P BSE Sensex was up 197.17 points or 0.73% at 27,223.87.
Help employers find you! Check out all the jobs and post your resume.
